David Barthel - Feb 8, 2022 Form 4 Insider Report for MARIZYME INC (MRZM)

Role
Chief Executive Officer, Director
Signature
/s/ David Barthel
Stock symbol
MRZM
Transactions as of
Feb 8, 2022
Transactions value $
$0
Form type
4
Date filed
2/9/2022, 04:17 PM
Previous filing
Jan 6, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRZM Stock Options (right to buy) Disposed to Issuer -400K -100% 0 Feb 8, 2022 Common Stock 400K $2.25 Direct F1
transaction MRZM Stock Options (right to buy) Award +400K 400K Feb 8, 2022 Common Stock 400K $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted as of October 31, 2021. The option vested as to 40,000 shares upon the original option's grant date of October 31, 2021 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated as of October 31, 2021, as amended on February 8, 2022. The balance of 360,000 shares vest on a quarterly basis over the three (3) year period following October 31, 2021 in equal installments.